Very severe HLA B27-associated panuveitis mimicking endophthalmitis: A case series

Ocular Immunology and Inflammation

Volumn 18, Issue 2, 2010, Pages 139-141

  Sanghvi, Chintan ^a   Mercieca, Karl ^a   Jones, Nicholas P ^a  

^a MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

HLA B27 associated uveitis; Infective endophthalmitis; Severe panuveitis

Indexed keywords

AZATHIOPRINE; CEFUROXIME; CORTICOSTEROID; HLA B27 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PREDNISOLONE; STEROID; TRIAMCINOLONE ACETONIDE; VANCOMYCIN;

ADULT; ANKYLOSING SPONDYLITIS; AQUEOUS HUMOR; ARTICLE; CASE REPORT; CATARACT; CATARACT EXTRACTION; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; DEMOGRAPHY; DISEASE COURSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; ENDOPHTHALMITIS; EYE SYNECHIA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRIDOTOMY; LENSECTOMY; LOW DRUG DOSE; MALE; NEODYMIUM LASER; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; TREATMENT OUTCOME; UVEITIS; VISUAL ACUITY; VITRECTOMY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CATARACT EXTRACTION; DIAGNOSIS, DIFFERENTIAL; ENDOPHTHALMITIS; FEMALE; HLA-B27 ANTIGEN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LENS IMPLANTATION, INTRAOCULAR; MALE; PANUVEITIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77950579789     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.3109/09273940903560236     Document Type: Article

References (9)

1. Tay-Kearney ML, Schwam BL, Lowder C, et al.Clinical features and associated systemic diseases of HLA-B27 uveitis. Am J Ophthalmol. 1996; 121:47-56.
2. Monnet D, Breban M, Hudry C, et al. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27 uveitis: a study of 175 cases. Ophthalmology. 2004;111:802-809.
3. Rothova A, van Veenedaal WG, Linssen A, et al. Clinical features of acute anterior uveitis. Am J Ophthalmol. 1987; 103:137-145.
4. Jabs DA, Nussenblatt RB, Rosenbaum JT;, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data: results of the First International Workshop. Am J Ophthalmol. 2005; 140:509-516.
5. Smith JR. HLA-B27-associated uveitis. Ophthalmol Clin North Am. 2002; 15:297-307.
6. Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46:1-18.
7. Verity DH, Marr JE, Ohno S, et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999; 54:213-220.
8. Power WJ, Rodriguez A, Pedroza-seres M, et al. Outcomes in anterior uveitis associated with the HLA-B27 haplotype. Ophthalmology. 1998; 105:1646-1651.
9. Rodriguez A, Akova YA, Pedroza-seres M, et al. Posterior segment ocular manifestations in patients with HLA-B27-associated uveitis. Ophthalmology. 1994; 101:1267-1274.